Human thymus-dependent lymphocytes (T cells) are defined by their ability to form spontaneous rosettes (E-rosettes) with sheep erythrocytes (SRBC) (1-3). Recently, several murine monoclonal antibodies that recognize distinct differentiation antigens on human T cells have been described (4-11). We report here a monoclonal antibody, designated 9.6, that identifies a 50,000-dalton surface protein that appears to be present on all E-rosette-forming cells. Blocking and lysostripping experiments indicate that this monoclonal antibody reacts either with the E receptor itself or with a closely associated structure.
culture, designated 9.6, were serially cloned four times by limiting-dilution and then inoculated intraperitoneally into Pristane-primed (Aldrich Chemical Co., Inc., Milwaukee, Wis.) BALB/c mice for the production of antibody-containing ascites fluid. The immunoglobulin produced by the 9.6 hybrid was identified as IgG2b by immunodiffusion.
Serological Analysis. Methods for complement-dependent microcytotoxicity, quantitative cytotoxicity (using trypan blue as indicator), and indirect immunofluorescence assays have been previously described (9, 11) . A fluorescein-conjugated affinity-purified goat anti-mouse IgG serum (Litton Bionetics Inc.) was used for indirect immunofluorescence. In some experi~ ments rhodamine-conjugated goat F(ab')2 fragments specific for mouse IgG were used (this reagent was generously provided by Dr. Shu Man Fu, The Rockefeller University, New York). Comparative studies were carried out using three additional monoclonal antibodies recognizing distinct markers for human lymphocytes. Antibody 9.3 reacts with a 45,000-dahon surface protein expressed by 70-80% of peripheral E + cells (9) ; antibody 10.2 reacts with a 65,000-to 67,000-dahon surface protein expressed by 85-95% of peripheral blood E + cells (11) ; and antibody 7.2 reacts with a framework determinant of the human Ia bimolecular complex (9) .
Blocking of E Rosette Formation and Lysostrippmg. Cells were incubated in medium that contained monoclonal antibody for 30 min at 22°C and then washed three times. In blocking experiments, these cells were subsequently assayed for E rosette formation. In lysostripping experiments, treated cells were incubated with affinity-purified goat anti-mouse IgG serum (fluorescein conjugated) for 45 rain at 37~'C, washed three times, and then tested for rosette formation.
Immune Prectpitation of Cell Membranes. Cells of the leukemic T cell line Jurkat were washed twice in phosphate-buffered safine, pH 7.2, and surface labeled by the 125I-lactoperoxidase method (14) with minor modification (15) . Labeled ceils were disrupted in cell lysis buffer that contained 0.5% Nonidet P-40 (15) and 2% of the protease inhibitor aprotinin (Sigma Chemical Co., St. Louis, Mo.). The lysate was cleared of nonsolubilized cellular structures and free 125I by uhracentrifugation and chromatography on a Sephadex G-25 column as described elsewhere (16) .
Before use in immune precipitation analysis, the cell lysate was treated by sequential incubation (1 h each at 4°C) with AKR normal mouse serum (1:40 dilution) and Staphylococcus aureus, Cowan I strain (30 mg) (17) . The S. aureus was removed from the reaction mixture by centrifugation at 1,500 g for 10 min. The concentration of sodium dodecyl sulfate (SDS) in the lysate was adjusted to 0.1% and the immune precip!tation reactions initiated by the addition 6 of 5 #1 of appropriately diluted antibody to 95-#1 (I0 cpm) aliquots of radiolabeled lysate. The mixture was incubated for 1 h on ice and the reaction then terminated by fhe addition of 3.5 mg S. aureus for 30 min on ice. The S. aureus pellet was washed five times in buffer that contained 0.5% NP-40 and 0.1% SDS (15) . Radiolabeled proteins bound to the pellet were extracted by incubation with 50 #1 of sample electrophoresis buffer (0.062 M Tris-HCl, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.02% bromphenol blue, pH 6.8) for 5 min at 100°C and then analyzed by polyacrylamide gel electrophoresis (PAGE) in the presence of SDS (SDS-PAGE) in 10% slab gels (18) . Radiolabeled bands in the dried gel were identified by radioautography (Kodak NS-2T film [Eastman Kodak Co., Rochester, N. Y.] with GAFMED Rarex B Mid Speed intensifying screen [GAF Corp., New York] with exposure at -70°C) (19) .
Results and Discussion
The 9.6 antigen was present on peripheral blood T cells and thymocytes, but was not detected on mononuclear cells of peripheral blood or bone marrow after removal ofT cells by E-rosetting (Table I ). T cells purified by passage over nylon wool followed by centrifugation of E + cells over Ficoll-Hypaque were >99% positive with 9.6 antibody. Thymocytes were also >99% positive for the 9.6 antigen. Cells from B lymphoid lines were uniformly negative.
A high degree of concordance between E-rosette formation and expression of 9.6 antigen was observed in testing cells from a variety of sources (Table I) . Similar numbers of 9.6-positive and E + cells were found in PBL, thymus, bone marrow, and long-term-cultured T cells. Expression of 9.6 antigen also correlated with E-rosetting in cells of leukemic T cell lines. Only the E + leukemic T cell lines 8402, Jurkat, and Molt-4F were 9.6 positive, each demonstrating equal numbers of E + and 9.6-positive <1 (2) (7) <l ( cells. Molt-4F cells, enriched for E + cells were 9.6 positive, whereas Molt-4F cells depleted of E + cells were 9.6 negative. Cells from patients with T cell ALL whose leukemic blasts formed E-rosettes were 9.6 positive. Leukemic blasts from patients with null cell ALL were 9.6 negative. The association between the E receptor and the 9.6 antigen was further investigated by blocking experiments. Cells preincubated with antibody 9.6 did not form E-rosettes (Table II) . Incubation with either of the two other monoelonal T cell antibodies, 9.3 (data not shown) or 10.2, did not inhibit E-rosetting. Rosette inhibition by antibody 9.6 paralleled its activity in a complement-mediated cytotoxicity assay. Lysostripping of cells incubated with monoclonal antibody was performed to determine whether the E receptor and the 9.6 antigen could be distinguished by cocapping. Cells lysostripped of 9.6 antigen did not form E-rosettes, whereas cells lysostripped of the 10.2 antigen were still capable of rosette formation (Table III) . Capping of antigen-antibody complexes appeared complete, as assessed by indirect immunofluorescence (Table III) and quantitative cytotoxicity (data not shown). It appeared, therefore, that the failure of cells stripped of 9.6 antigen to form E rosettes was not a result of residual blocking antibody. When cells were lysostripped of 9.6 antigen and then incubated in fresh medium at 37°C for 18 h, they again expressed 9.6 antigen and formed E-rosettes.
Results of precipitation assays with antibody 9.6 and an 12~I-labeled lysate of the leukemic T cell line Jurkat are presented in Fig. 1 . The antibody precipitated a single polypeptide of -50,000 mol wt. In this same assay are shown the results with antibodies 9.3 and 10.2, which precipitated proteins of 45,000 and 67,000 daltons, respectively. The 45,000-dalton protein precipitated by 9.3 antibody was not associated with flz-microglobulin. This was in contrast to that observed with precipitates formed by antibodies against HLA heavy chain (W6/32) and fl2-microglobulin. Control reactions performed with normal mouse serum and monoclonal antibody 7.2 against human Ia antigen failed to show precipitation with the cell lysate. In additional precipitation assays with 12~I-labeled lysates of normal T cells (data not shown), the 9.6 antibody demonstrated essentially similar results to those found with the Jurkat cell line, although the antigen precipitated from normal T cells showed a slightly more disperse pattern on the gel. These results suggested that the antigen precipitated by 9.6 may have variable glycosylation patterns on T cells from different sources. Alternatively, the different pattern on gels might reflect mild proteolytic degradation of the antigen that varied from one T cell type to another.
Summary
We describe a new monoclonal murine antibody that reacts with a 50,000-mol wt polypeptide that appears to be present on all E-rosetting cells. We conclude that this FtG. 1. Radioimmune precipitation assays with monoclonal antibodies and a lzSI-surface-labeled lysate of the leukemic T cell line Jurkat. Aliquots of radiolabeled cell lysate were tested in immune precipitation assays with: (1) normal mouse serum (1:50 dilution); (2) monoclonal 7.2 antibody from ascites fluid (1:500) which recognizes a monomorphic determinant of human la antigens (9); (3) rabbit anti-human/32-microglobulin serum (Dakopatts, Copenhagen, Denmark; 1:50 dilution); (4) monoclonal antibody W6/32 (Allied Chemical Corp., Morristown, N.J.; 1:100 dilution) which recognizes a monomorphic determinant of the HLA-A,B,C heavy chain (21); (5) monoclonal 9.3 antibody from ascites fluid (1:500 dilution) which recognizes a 45,000-dahon protein specific for T cells (9); (6) monoclonal 10.2 antibody from ascites fluid (1:500 dilution) which recognizes a 65,000-67,000 dalton protein specific for T ceils (11); and (7) monoclonal 9.6 antibody from ascites fluid (1:500 dilution). Immune precipitates were collected on S. aureus, eluted in electrophoresis buffer that contained 2-mercaptoethanol, and analyzed by SDS-PAGE. Radioautography of the dried gel was enhanced for 2 d on x-ray intensifying screens. a n t i g e n is either identical to or closely associated with the E receptor because of (a) the high degree of c o n c o r d a n c e b e t w e e n E-rosette f o r m a t i o n a n d 9.6 a n t i g e n expression, (b) the i n h i b i t i o n of rosette formation b y p r e i n c u b a t i o n of cells with 9.6 a n t i b o d y , a n d (c) the observed failure of cells lysostripped of 9.6 a n t i g e n to form E-rosettes. T h i s last finding suggests c o c a p p i n g of 9.6 a n t i g e n a n d the E receptor.
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